Annandale Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,820	Closed	-$131K	–	137
2023 Q4	$131K	Buy	55,820 +30,820	+123%	+$72.3K	0.02%	126
2023 Q3	$47K	Buy	+25,000	New	+$47K	0.01%	125